Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
215 studies found for:    Pituitary Tumors
Show Display Options
RSS Create an RSS feed from your search for:
Pituitary Tumors
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
Condition: Pituitary Tumours
Intervention: Procedure: Gallium-68 DOTATOC PET
2 Withdrawn Temozolomide in Treating Patients With Invasive Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: DNA methylation analysis;   Genetic: microarray analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
3 Not yet recruiting Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Conditions: Pituitary Tumor;   ACTH-producing Pituitary Tumour
Intervention: Drug: Pasireotide LAR
4 Unknown  Pituitary Tumor Surveillance: Pathogenic Correlation
Condition: Pituitary Tumor
Intervention:
5 Recruiting PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
Condition: Pituitary Tumor
Intervention:
6 Unknown  The Observational Study of Growth Hormone-secreting Pituitary Tumors
Conditions: Acromegaly;   Pituitary Tumor
Intervention:
7 Completed Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors
Condition: Pituitary Tumors
Intervention: Drug: Technetium Tc 99m EC20
8 Completed Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Conditions: Acromegaly;   Nonfunctioning Pituitary Tumor
Intervention:
9 Recruiting Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Conditions: Pituitary Adenomas;   Prolactinomas
Intervention: Drug: Lapatinib
10 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:
11 Completed Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
Condition: Pituitary Neoplasms
Intervention:
12 Recruiting Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor
Condition: Pituitary Tumor
Interventions: Drug: total intravenous anesthesia (TIVA);   Drug: inhalation anesthesia group
13 Active, not recruiting Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Conditions: Pituitary Tumor;   Pain
Interventions: Drug: IV Caldolor (IV Ibuprofen);   Drug: IV Ibuprofen placebo
14 Terminated
Has Results
Rosiglitazone in Treating Patients With Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: rosiglitazone maleate
15 Active, not recruiting Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)
Condition: Pituitary Tumors
Intervention:
16 Recruiting Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Conditions: Pituitary Adenoma;   Pituitary Tumor
Interventions: Procedure: Surgical intervention for CNFA;   Radiation: Radiotherapy for CNFA
17 Terminated
Has Results
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Condition: Cushing's Disease
Intervention: Drug: rosiglitazone maleate
18 Active, not recruiting Peri-Operative Steriod Management in Patients
Conditions: Pituitary Adenoma;   Pituitary Diseases
Interventions: Drug: hydrocortisone;   Drug: dexamethasone
19 Not yet recruiting Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
Condition: Pituitary Neoplasms
Interventions: Drug: Dexmedetomidine;   Drug: Sodium Chloride 0.9%
20 Terminated Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
Conditions: Growth Hormone Deficiency;   Pituitary Tumor
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years